海爾智家(06690.HK)擬配售4141.36萬股籌資11.5億港元
格隆匯1月11日丨海爾智家(06690.HK)公吿,於2022年1月11日,公司與配售代理訂立配售協議,公司擬配售4141.36萬股配售股份,佔現有已發行股份及H股總數分別約0.441%及1.469%;及經根據配售將予發行的配售股份擴大的已發行股份及H股總數分別約0.439%及1.448%。配售股份將根據一般性授權予以配發及發行。
來自配售的所得款項總額及所得款項淨額將分別為約11.6億港元及約11.5億港元。公司擬將所得款項淨額主要用於支持海外業務擴展及ESG相關領域投資。
公司相信將所得款項淨額不僅可以為其海外業務提供適時財務支持,還可以引入能為公司長遠發展作出貢獻的投資者。承配人所承諾相對較長的禁售期(不少於6個月)亦對公司及股東整體有利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.